메뉴 건너뛰기




Volumn 50, Issue 2, 2009, Pages 206-214

Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: Results from FHDH ANRS CO4

Author keywords

Cohort study; HIV; Hodgkin lymphoma; Interleukin 2; non Hodgkin lymphoma

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 1;

EID: 60749083560     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318190018c     Document Type: Article
Times cited : (8)

References (40)
  • 1
    • 0023907493 scopus 로고
    • Interleukin-2: Inception, impact, and implications
    • Smith KA. Interleukin-2: inception, impact, and implications. Science. 1988;240:1169-1176.
    • (1988) Science , vol.240 , pp. 1169-1176
    • Smith, K.A.1
  • 2
    • 33845506881 scopus 로고    scopus 로고
    • Cytokine-based modulation of immune function in HIV infection
    • Levy Y. Cytokine-based modulation of immune function in HIV infection. Curr Opin HIV AIDS. 2006;1:67-71.
    • (2006) Curr Opin HIV AIDS , vol.1 , pp. 67-71
    • Levy, Y.1
  • 3
    • 17444385673 scopus 로고    scopus 로고
    • Partial immune reconstitution following highly active antiretroviral therapy: Can adjuvant interleukin-2 fill the gap?
    • Marchetti G, Franzetti F, Gori A. Partial immune reconstitution following highly active antiretroviral therapy: can adjuvant interleukin-2 fill the gap? J Antimicrob Chemother. 2005;55:401-409.
    • (2005) J Antimicrob Chemother , vol.55 , pp. 401-409
    • Marchetti, G.1    Franzetti, F.2    Gori, A.3
  • 4
    • 0013610170 scopus 로고    scopus 로고
    • Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
    • Kovacs JA, Vogel S, Albert JM, et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med. 1996;335:1350-1356.
    • (1996) N Engl J Med , vol.335 , pp. 1350-1356
    • Kovacs, J.A.1    Vogel, S.2    Albert, J.M.3
  • 5
    • 0033526641 scopus 로고    scopus 로고
    • Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: A randomised controlled trial. ANRS 048 study group
    • Levy Y, Capitant C, Houhou S, et al. Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet. 1999;353:1923-1929.
    • (1999) Lancet , vol.353 , pp. 1923-1929
    • Levy, Y.1    Capitant, C.2    Houhou, S.3
  • 6
    • 0001027244 scopus 로고    scopus 로고
    • A randomized trial of high-versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection
    • Davey RT Jr, Chaitt DG, Albert JM, et al. A randomized trial of high-versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. J Infect Dis. 1999;179:849-858.
    • (1999) J Infect Dis , vol.179 , pp. 849-858
    • Davey Jr, R.T.1    Chaitt, D.G.2    Albert, J.M.3
  • 7
    • 0004781509 scopus 로고    scopus 로고
    • Immunologic and virologie effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial
    • Davey RT Jr, Murphy RL, Graziano FM, et al. Immunologic and virologie effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial. JAMA. 2000;284:183-189.
    • (2000) JAMA , vol.284 , pp. 183-189
    • Davey Jr, R.T.1    Murphy, R.L.2    Graziano, F.M.3
  • 8
    • 0037436193 scopus 로고    scopus 로고
    • Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-I infection: A randomized controlled trial
    • Levy Y, Durier C, Krzysiek R, et al. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-I infection: a randomized controlled trial. AIDS. 2003;17:343-351.
    • (2003) AIDS , vol.17 , pp. 343-351
    • Levy, Y.1    Durier, C.2    Krzysiek, R.3
  • 9
    • 3042831250 scopus 로고    scopus 로고
    • CD4 cell response to 3 doses of subcutaneous interleukin 2: Meta-analysis of 3 Vanguard studies
    • Arduino RC, Nannini EC, Rodriguez-Barradas M, et al. CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies. Clin Infect Dis. 2004;39:115-122.
    • (2004) Clin Infect Dis , vol.39 , pp. 115-122
    • Arduino, R.C.1    Nannini, E.C.2    Rodriguez-Barradas, M.3
  • 10
    • 0035822985 scopus 로고    scopus 로고
    • Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients
    • Gougeon ML, Rouzioux C, Liberman I, et al. Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients. AIDS. 2001;15:1729-1731.
    • (2001) AIDS , vol.15 , pp. 1729-1731
    • Gougeon, M.L.1    Rouzioux, C.2    Liberman, I.3
  • 11
    • 11144353584 scopus 로고    scopus 로고
    • Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection
    • Farel CE, Chaitt DG, Hahn BK, et al. Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood. 2004;103:3282-3286.
    • (2004) Blood , vol.103 , pp. 3282-3286
    • Farel, C.E.1    Chaitt, D.G.2    Hahn, B.K.3
  • 12
    • 33645027967 scopus 로고    scopus 로고
    • Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients
    • Keh CE, Shen JM, Hahn B, et al. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients. AIDS. 2006;20:361-369.
    • (2006) AIDS , vol.20 , pp. 361-369
    • Keh, C.E.1    Shen, J.M.2    Hahn, B.3
  • 13
    • 33748155708 scopus 로고    scopus 로고
    • Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials
    • Lifson AR, Rhame FS, Belloso WH, et al. Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials. HIV Clin Trials. 2006;7:125-141.
    • (2006) HIV Clin Trials , vol.7 , pp. 125-141
    • Lifson, A.R.1    Rhame, F.S.2    Belloso, W.H.3
  • 14
    • 0036721196 scopus 로고    scopus 로고
    • Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy
    • Malnati M, Broccolo F, Nozza S, et al. Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. Blood. 2002;100:1575-1578.
    • (2002) Blood , vol.100 , pp. 1575-1578
    • Malnati, M.1    Broccolo, F.2    Nozza, S.3
  • 15
    • 61349197977 scopus 로고    scopus 로고
    • Agence Nationale de Recherches sur le SIDA et las hépatites virales. ANRS trials 048, 079, 082 [ILSTIM], 093 [VACCIL-2], 095 [PRIMOVAC], 101 [ESPRIT], 118 [ILIADE], 119 [INTERSTART], 122 [SILCAAT], and 123 [ETOILE], Available at: www.anrs.fr/index.php/anrs/vih_sida/clinique/ repertoire_des_etudes_cliniques. Accessed November 24, 2008.
    • Agence Nationale de Recherches sur le SIDA et las hépatites virales. ANRS trials 048, 079, 082 [ILSTIM], 093 [VACCIL-2], 095 [PRIMOVAC], 101 [ESPRIT], 118 [ILIADE], 119 [INTERSTART], 122 [SILCAAT], and 123 [ETOILE], Available at: www.anrs.fr/index.php/anrs/vih_sida/clinique/ repertoire_des_etudes_cliniques. Accessed November 24, 2008.
  • 16
    • 0037131199 scopus 로고    scopus 로고
    • Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: The ILSTIM study-ANRS 082
    • Katlama C, Carcelain G, Duvivier C, et al. Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study-ANRS 082. AIDS. 2002;16:2027-2034.
    • (2002) AIDS , vol.16 , pp. 2027-2034
    • Katlama, C.1    Carcelain, G.2    Duvivier, C.3
  • 17
    • 84974610155 scopus 로고    scopus 로고
    • Institut national de la santé et de la recherche médicale Unité U 720, Available at:, Accessed November 24, 2008
    • Institut national de la santé et de la recherche médicale Unité U 720. French Hospital Database on HIV (FHDH). Available at: http://ccde.fr/_fold/fl-1182178152-395.pdf. Accessed November 24, 2008.
    • French Hospital Database on HIV (FHDH)
  • 20
    • 84921009277 scopus 로고
    • Expanded European AIDS definition
    • Ancelle-Park E. Expanded European AIDS definition. Lancet. 1993;341:441.
    • (1993) Lancet , vol.341 , pp. 441
    • Ancelle-Park, E.1
  • 21
    • 0024592074 scopus 로고
    • The impact of confounder selection criteria on effect estimation
    • Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125-137.
    • (1989) Am J Epidemiol , vol.129 , pp. 125-137
    • Mickey, R.M.1    Greenland, S.2
  • 22
    • 4444226528 scopus 로고    scopus 로고
    • The epidemiology of non-Hodgkin's lymphoma
    • Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene. 2004;23:6524-6534.
    • (2004) Oncogene , vol.23 , pp. 6524-6534
    • Fisher, S.G.1    Fisher, R.I.2
  • 24
    • 61349169994 scopus 로고    scopus 로고
    • Guizard AV, Carli PM, Troussard X. Lymphome malin non Hodgkinien et Maladie de Hodgkin. In: Remontet L, Buemi A, Velten M, et al eds. Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000. Réseaux Français des registres de cancer, Hôpitaux de Lyon, Inserm, Institut de Veille Sanitaire, 2003;155-166.
    • Guizard AV, Carli PM, Troussard X. Lymphome malin non Hodgkinien et Maladie de Hodgkin. In: Remontet L, Buemi A, Velten M, et al eds. Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000. Réseaux Français des registres de cancer, Hôpitaux de Lyon, Inserm, Institut de Veille Sanitaire, 2003;155-166.
  • 25
    • 3042796713 scopus 로고    scopus 로고
    • B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS
    • Grulich AE, Wan X, Law MG, et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS. 2000;14:133-140.
    • (2000) AIDS , vol.14 , pp. 133-140
    • Grulich, A.E.1    Wan, X.2    Law, M.G.3
  • 26
    • 0035804852 scopus 로고    scopus 로고
    • Association of cancer with AIDS-related immunosuppression in adults
    • Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
    • (2001) JAMA , vol.285 , pp. 1736-1745
    • Frisch, M.1    Biggar, R.J.2    Engels, E.A.3
  • 27
    • 0035760292 scopus 로고    scopus 로고
    • Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy
    • Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood. 2001;98:3406-3412.
    • (2001) Blood , vol.98 , pp. 3406-3412
    • Kirk, O.1    Pedersen, C.2    Cozzi-Lepri, A.3
  • 28
    • 31044447107 scopus 로고    scopus 로고
    • Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France
    • Bonnet F, Balestre E, Thiebaut R, et al. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France. Clin Infect Dis. 2006;42:411-417.
    • (2006) Clin Infect Dis , vol.42 , pp. 411-417
    • Bonnet, F.1    Balestre, E.2    Thiebaut, R.3
  • 29
    • 0037165879 scopus 로고    scopus 로고
    • Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis
    • Grulich AE, Li Y, McDonald A, et al. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 2002;16:1155-1161.
    • (2002) AIDS , vol.16 , pp. 1155-1161
    • Grulich, A.E.1    Li, Y.2    McDonald, A.3
  • 30
    • 33845237838 scopus 로고    scopus 로고
    • Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
    • Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108:3786-3791.
    • (2006) Blood , vol.108 , pp. 3786-3791
    • Biggar, R.J.1    Jaffe, E.S.2    Goedert, J.J.3
  • 31
    • 20144381973 scopus 로고    scopus 로고
    • Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
    • Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-432.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 425-432
    • Clifford, G.M.1    Polesel, J.2    Rickenbach, M.3
  • 32
    • 0142026064 scopus 로고    scopus 로고
    • Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients
    • Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;21:3447-3453.
    • (2003) J Clin Oncol , vol.21 , pp. 3447-3453
    • Herida, M.1    Mary-Krause, M.2    Kaphan, R.3
  • 33
    • 34047253751 scopus 로고    scopus 로고
    • Infectious agents as causes of non-Hodgkin lymphoma
    • Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:401-404.
    • (2007) Cancer Epidemiol Biomarkers Prev , vol.16 , pp. 401-404
    • Engels, E.A.1
  • 34
    • 33845266758 scopus 로고    scopus 로고
    • Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study
    • Franceschi S, Polesel J, Rickenbach M, et al. Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort Study. Br J Cancer. 2006;95:1598-1602.
    • (2006) Br J Cancer , vol.95 , pp. 1598-1602
    • Franceschi, S.1    Polesel, J.2    Rickenbach, M.3
  • 35
    • 34047244362 scopus 로고    scopus 로고
    • Environmental and behavioral factors and the risk of non-Hodgkin lymphoma
    • Hartge P, Smith MT. Environmental and behavioral factors and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:367-368.
    • (2007) Cancer Epidemiol Biomarkers Prev , vol.16 , pp. 367-368
    • Hartge, P.1    Smith, M.T.2
  • 36
    • 7244224775 scopus 로고    scopus 로고
    • Sun exposure may protect against non-Hodgkin lymphoma: A case-control study
    • Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer. 2004;112:865-871.
    • (2004) Int J Cancer , vol.112 , pp. 865-871
    • Hughes, A.M.1    Armstrong, B.K.2    Vajdic, C.M.3
  • 38
    • 34147154891 scopus 로고    scopus 로고
    • Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): A pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
    • Wang SS, Slager SL, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109:3479-3488.
    • (2007) Blood , vol.109 , pp. 3479-3488
    • Wang, S.S.1    Slager, S.L.2    Brennan, P.3
  • 39
    • 10744229561 scopus 로고    scopus 로고
    • Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women
    • Zheng T, Holford TR, Leaderer B, et al. Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol. 2004;159:454-466.
    • (2004) Am J Epidemiol , vol.159 , pp. 454-466
    • Zheng, T.1    Holford, T.R.2    Leaderer, B.3
  • 40
    • 34047250459 scopus 로고    scopus 로고
    • Obesity, diet and risk of non-Hodgkin lymphoma
    • Skibola CF. Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:392-395.
    • (2007) Cancer Epidemiol Biomarkers Prev , vol.16 , pp. 392-395
    • Skibola, C.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.